Chengdu Kanghua Biological Products Co., Ltd. (SHE:300841)
China · Delayed Price · Currency is CNY 48.31
+1.72 (3.69%)
Jul 15, 2026, 3:04 PM CST
SHE:300841 Market Cap
SHE:300841 has a market cap or net worth of 6.05 billion as of July 14, 2026. Its market cap has decreased by -23.19% in one year.
Market Cap
6.05B
Enterprise Value
5.03B
Revenue
1.20B
Ranking
n/a
PE Ratio
26.72
Stock Price
48.31
Market Cap Chart
Since June 16, 2020, SHE:300841's market cap has decreased from 6.08B to 6.05B, a decrease of -0.42%. That is a compound annual growth rate of -0.07%.
| Date | Market Cap | % Change |
|---|---|---|
| Jul 14, 2026 | 6.05B | -35.52% |
| Dec 31, 2025 | 9.39B | 34.30% |
| Dec 31, 2024 | 6.99B | -32.58% |
| Dec 29, 2023 | 10.37B | -8.37% |
| Dec 30, 2022 | 11.32B | -40.88% |
| Dec 31, 2021 | 19.14B | -31.86% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Jun 16, 2020 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Daan Gene | 7.17B |
| Shanghai OPM Biosciences | 6.74B |
| Zhejiang Ausun Pharmaceutical | 6.68B |
| Youcare Pharmaceutical Group | 6.20B |
| Shouyao Holdings (Beijing) Co., LTD. | 6.11B |
| Xiangxue Pharmaceutical | 6.06B |
| Jiangsu Aidea Pharmaceutical Group | 6.03B |
| Wuhan Keqian Biology Co.,Ltd | 5.96B |